The global gabapentin drug market is anticipated to grow at a CAGR of 3.4% during the forecast period. The rising prevalence of epilepsy disease has created a demand for the development of new drugs for its treatment which in turn drives the global gabapentin drugs market growth. The market growth is driven by the strong focus of pharmaceutical companies and research organizations on the R&D of drugs for gabapentin, creating an increased incidence of seizures. For instance, in 2019, the drug company Lupine had launched its standard Clobazam tablets in the US to treat a patient suffering from epilepsy since childhood and the company introduced Clobazam tablets in doses of 10 mg and 20 mg, after receiving approval from the USFDA.
Get Free Sample link @ https://www.omrglobal.com/request-sample/gabapentin-drug-market
Gabapentin is an anti-convulsants, a type of medication that helps control seizures in people with epilepsy disorder. Another type of gabapentin is used to treat chronic leg pain or certain types of nerve pain and the mechanism of action of gabapentin is to alter electrical impulses in the brain and trigger neurotransmitters, that send signals between nerve cells. In addition, leading pharmaceutical companies are focusing on the development of drugs for epilepsy disorder treatment.
A full report of Global Gabapentin Drug Market available @ https://www.omrglobal.com/industry-reports/gabapentin-drug-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Gabapentin Drug Market by Type
- Capsule
- Tablet
- Oral Solution
Global Gabapentin Drug Market by Application
- Epilepsy
- Neuropathic Pain
- Restless Legs Syndrome
Regional Analysis
- North America
- US
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Alkem Laboratories, Ltd.
- Amneal Pharmaceuticals LLC
- Apotex Inc.
- Aurobindo Pharma, Ltd.
- Breckenridge Pharmaceutical, Inc.
- Cipla, Ltd.
- Glenmark Pharmaceuticals, Ltd.
- Hi-tech Pharmaceuticals
- Invagen Pharmaceuticals
- Marksans Pharma, Ltd.
- Mylan N.V.
- Sun Pharmaceutical Industries, Ltd.
- Taro Pharmaceutical Industries, Ltd.
- Teva Pharmaceutical Industries, Ltd.
- Zydus Pharmaceuticals, Inc.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global gabapentin drug market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/gabapentin-drug-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
